Journal profile · BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Minerva Biotechnology and Biomolecular Research

ISSN 2724-542X · eISSN 2724-5934 · Edizioni Minerva Medica

Minerva Biotechnology and Biomolecular Research: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 0.59; hybrid open access; 19 articles in 2025; indexed in SCIE and Scopus.

Impact factor0.59Latest value listed by LetPub
CAS zoneZone 4 · Biology2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Biology
Review time—No reports yet
APC—No source gives fee information
Acceptance—No reports yet
Articles per year192025 · OpenAlex count

Scope

Aims, scope and focus

Minerva Biotechnology and Biomolecular Research is published by Edizioni Minerva Medica and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Liver Disease Diagnosis and Treatment, SARS-CoV-2 and COVID-19 Research and MicroRNA in disease regulation, together about 18.6% of its articles. Its main subfields are Infectious Diseases and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)

Research area (LetPub): BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Liver Disease Diagnosis and TreatmentMedicine6.9%
  2. SARS-CoV-2 and COVID-19 ResearchMedicine6.2%
  3. MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5.5%
  4. Gut microbiota and healthBiochemistry, Genetics and Molecular Biology5.5%
  5. Nanoparticles: synthesis and applicationsMaterials Science4.8%
  6. Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology4.8%
  7. Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology4.8%
  8. COVID-19 Clinical Research StudiesMedicine4.1%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
LevelCategoryZone
MajorBiologyZone 4
MinorBiotechnology & Applied MicrobiologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Biology Zone 4
LevelCategoryZone
MajorBiologyZone 4
MinorBiotechnology & Applied MicrobiologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 4
LevelCategoryZone
MajorBiologyZone 4
MinorBiotechnology & Applied MicrobiologyZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
0.59LetPub ·
CiteScore 2026-06
1.3LetPub ·
SJR 2026-06
0.16LetPub ·
SNIP 2026-06
0.16LetPub ·
h-index
10OpenAlex ·
i10-index
10OpenAlex ·
2-year mean citedness
0.61OpenAlex ·
Self-citation rate
16.7%LetPub ·
Share of gold OA articles
6.35%LetPub ·

Volume

Articles per year
19LetPub ·

Articles by year OpenAlex count · 185 in total · the current year is incomplete

YearArticlesOpen accessCitations
20261724
20251905
202435234
202316125
202229261
202127299

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Edizioni Minerva Medica
ISSN
2724-542X
Electronic ISSN
2724-5934

FAQ

Frequently asked questions about Minerva Biotechnology and Biomolecular Research

What CAS zone is Minerva Biotechnology and Biomolecular Research in?

In the 2025 upgraded edition of the CAS Journal Ranking, Minerva Biotechnology and Biomolecular Research is in Zone 4 of Biology, and in Zone 4 of the minor category Biotechnology & Applied Microbiology. In the 2026 Xinrui edition it is in Zone 4 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Minerva Biotechnology and Biomolecular Research?

The latest impact factor listed by LetPub is 0.59; CiteScore 1.3, h-index 10.

Which databases index Minerva Biotechnology and Biomolecular Research?

According to LetPub and DOAJ records, Minerva Biotechnology and Biomolecular Research is indexed in SCIE and Scopus.

Is Minerva Biotechnology and Biomolecular Research open access, and what is the APC?

Minerva Biotechnology and Biomolecular Research is a hybrid journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .